AEs	Adverse events
AUC	Area under the curve
CBR	Clinical benefit rate
CT	Computed tomography
CI	Confidence interval
EOC	Epithelial ovarian cancer
eGFR	Estimated glomerular filtration rate
FTC	Fallopian tube cancer
FIGO	International Federation of Gynecology and Obstetrics
ISC	Interval cytoreductive surgery
NCI-CTCAE	National Cancer Institute’s Common Terminology Criteria for Adverse Events
NACT	Neoadjuvant chemotherapy
MRI	Magnetic resonance image
ORR	Overall response rate
OS	Overall survival
PARP inhibitors	Poly(ADP-ribose) polymerase (PARP) inhibitors
PPSC	Primary peritoneal serous carcinoma
PSC	Primary cytoreductive surgery
PFS	Progression-free survival
PD	Progressive disease
RDI	Relative dose intensity
RECIST	Response Evaluation Criteria in Solid Tumors
RR	Risk ratio
VIF	Variance inflation factor